Construction of Monophosphine–Metal Complexes in Privileged Diphosphine-Based Covalent Organic Frameworks for Catalytic Asymmetric Hydrogenation
Journal of the American Chemical Society · 22.03.2023 · 145 (11) · 6100-6111
DOI: 10.1021/jacs.2c11037 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 10.03.2023. Verfasst von Zehao Zheng und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules and State Key Laboratory of Metal Matrix Composit…. Die Arbeit wurde bisher 80-mal zitiert (Crossref) und nennt 88 Literaturangaben. Gefördert von: Ministry of Science and Technology of the People's Republic of China, Science, Technology and Innovation Commission of Shenzhen Municipality, National Natural Science Foundation of China.
Abstract (Originalsprache)
Privileged diphosphine ligands that chelate many transition metals to form stable chelation complexes are essential in a variety of catalytic processes. However, the exact identity of the catalytically active moieties remains ambiguous because the chelated metal catalysts may undergo rearrangement during catalysis to produce monophosphine-metal complexes, which are hard to isolate and evaluate the activities. By taking advantage of the isolation of two phosphorus atoms, we demonstrate here the successful construction of chiral monophosphine-Ir/Ru complexes of diphosphine ligands in covalent organic frameworks (COFs) for enantioselective hydrogenation. By condensation of the tetraaldehyde of enantiopure MeO-BIPHEP and linear aromatic diamines, we prepare two homochiral two-dimensional COFs with ABC stacking, in which the two P atoms of each diphosphine are separated and fixed far apart. Post-synthetic metalations of the COFs thus afford the single-site Ir/Ru-monophosphine catalysts, in contrast to the homogeneous chelated analogues, that demonstrated excellent catalytic and recyclable performance in the asymmetric hydrogenation of quinolines and β-ketoesters, affording up to 99.9% enantiomeric excess. Owing to the fact that the porous catalyst is capable of adsorbing and concentrating hydrogen, the catalytic reactions are promoted under ambient/medium pressure, which are typically performed under high pressure for homogeneous catalysis. This work not only shows that monophosphine-metal complexes of diphosphines can be catalytically active centers for asymmetric hydrogenation reactions but also provides a new strategy to prepare new types of privileged phosphine-based heterogeneous catalysts.
Autor:innen und Institutionen
- School of Chemistry and Chemical Engineering, Frontiers Science Center for Transformative Molecules and State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, Shanghai 200240, China.
ORCID-Profile: Chen Yuan, Jinqiao Dong, Yan Liu, Yong Cui
Förderung
- Ministry of Science and Technology of the People's Republic of China
- Science, Technology and Innovation Commission of Shenzhen Municipality
- National Natural Science Foundation of China
- Key Project of Basic Research of Shanghai
Zitieren
APA
Zheng, Z., Yuan, C., Sun, M., Dong, J., Liu, Y., & Cui, Y. (2023). Construction of Monophosphine–Metal Complexes in Privileged Diphosphine-Based Covalent Organic Frameworks for Catalytic Asymmetric Hydrogenation. Journal of the American Chemical Society, 145(11), 6100-6111. https://doi.org/10.1021/jacs.2c11037
Vancouver
Zheng Z, Yuan C, Sun M, Dong J, Liu Y, Cui Y. Construction of Monophosphine–Metal Complexes in Privileged Diphosphine-Based Covalent Organic Frameworks for Catalytic Asymmetric Hydrogenation. Journal of the American Chemical Society. 2023;145(11):6100-6111. doi:10.1021/jacs.2c11037
BibTeX
@article{Zheng2023,
author = {Zheng, Zehao and Yuan, Chen and Sun, Meng and Dong, Jinqiao and Liu, Yan and Cui, Yong},
title = {Construction of Monophosphine–Metal Complexes in Privileged Diphosphine-Based Covalent Organic Frameworks for Catalytic Asymmetric Hydrogenation},
journal = {Journal of the American Chemical Society},
year = {2023},
volume = {145},
number = {11},
pages = {6100--6111},
doi = {10.1021/jacs.2c11037}
}
EUVIMED